icon-folder.gif   Conference Reports for NATAP  
 
  EASL 2024
June 5-8, Milan, Italy 		Back grey_arrow_rt.gif
 
 
 
Safety and efficacy of REP 2139-Mg in hepatitis D patients with advanced liver disease: an international compassionate use program
 
 
  EASL 2024 June 5-8 Milan Italy

0611241

0611242

0611243

0611244

0611245

0611246

0611247

0611248

0611249

06112410

06112411

06112412

06112413